|Mr. Andrew A. DeFrancesco||Chief Investment Officer & Chairman||N/A||N/A||1970|
|Mr. Brady Cobb||CEO & Director||N/A||N/A||N/A|
|Mr. Maghsoud Dariani||Chief Scientific Officer||N/A||N/A||1953|
|Prof. Michael Barnes||Chief Medical Officer||N/A||N/A||N/A|
SOL Global Investments Corp. operates as a cannabis company in the United States. The company was formerly known as Scythian Biosciences Corp. and changed its name to SOL Global Investments Corp. in October 2018. SOL Global Investments Corp. is based in Toronto, Canada.
SOL Global Investments Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.